Enterobacterial analysis for the precise medical care (precision medicine) for diabetes, non-alcoholic lipid liver disease / non-alcoholicity fat hepatitis, inflammatory bowel disease, and irritable bowel syndrome.
Not Applicable
Recruiting
- Conditions
- diabetes, non-alcoholic lipid liver disease / non-alcoholicity fat hepatitis, inflammatory bowel disease (ulcerative colitis, Crohn's disease), irritable bowel disease, neuroimmune disease, lung cancer, esophageal cancer, gastric cancer, colorectal cancer
- Registration Number
- JPRN-UMIN000019486
- Lead Sponsor
- Kyoto Prefectural University of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 175
Inclusion Criteria
Not provided
Exclusion Criteria
1) Re-registration example to the examination 2) The patients with surgical operation within 12 weeks 3) In addition, the patient who judged an arrangement to the examination if the medical attendant was inappropriate 4) The patients who have stoma.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tendency of the enterobacterial flora of each disease compared to healthy control.
- Secondary Outcome Measures
Name Time Method